RecruitingNCT04481321

Clinical and Molecular Study of Endometriosis and Adenomyosis

ENDOCHAP Monocentric Cohort: Clinical and Molecular Study of Endometriosis and Adenomyosis


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

5,300 participants

Start Date

May 1, 2006

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 42 Years

Inclusion Criteria3

  • Women of age between - 18 and 42 years old.
  • In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass.
  • Having a radiological diagnosis made by a referral practitioner and/or operated in the department

Exclusion Criteria4

  • HIV-positive women, HBV and HCV
  • During pregnancy
  • Having a cancer diagnosis
  • Refusing to sign a consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBiological/Vaccine

Locations(1)

Port Royal, hospital cochin

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04481321


Related Trials